Long noncoding RNA RUSC1-AS1 promotes tumorigenesis in cervical cancer by acting as a competing endogenous RNA of microRNA-744 and consequently increasing Bcl-2 expression

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–2686.
   PubMed Web of Science ®Google Scholar
• Barra F, Lorusso D, Leone Roberti Maggiore U, et al. Investigational drugs for the treatment of cervical cancer. Expert Opin Invest Drugs. 2017;26:389–402.
   PubMed Web of Science ®Google Scholar
• Bosch FX, de Sanjose S. Chapter 1: human papillomavirus and cervical cancer–burden and assessment of causality. J Nat Cancer Inst Monogr. 2003;3–13.
   PubMedGoogle Scholar
• Yu Y, Zhang Y, Zhang S. MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells. Oncol Lett. 2013;6:468–474.
   PubMed Web of Science ®Google Scholar
• Ghebre RG, Grover S, Xu MJ, et al. Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol Rep. 2017;21:101–108.
   PubMed Web of Science ®Google Scholar
• Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63:88–105.
   PubMed Web of Science ®Google Scholar
• Kogo R, How C, Chaudary N, et al. The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget. 2015;6:1090–1100.
   PubMedGoogle Scholar
• Kanwal F, Lu C. A review on native and denaturing purification methods for non-coding RNA (ncRNA). J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1120:71–79.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–641.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29:452–463.
   PubMed Web of Science ®Google Scholar
• Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982.
   PubMed Web of Science ®Google Scholar
• Tao L, Wang X, Zhou Q. Long noncoding RNA SNHG16 promotes the tumorigenicity of cervical cancer cells by recruiting transcriptional factor SPI1 to upregulate PARP9. Cell Biol Int. 2020 Mar;44(3):773–784. doi:10.1002/cbin.11272. Epub 2019 Dec 25.
   Google Scholar
• Duan W, Nian L, Qiao J, et al. LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2. Eur Rev Med Pharmacol Sci. 2019;23:8211–8218.
   PubMed Web of Science ®Google Scholar
• Chang QQ, Chen CY, Chen Z, et al. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer. Radiol Oncol. 2019;53:443–452.
   PubMed Web of Science ®Google Scholar
• Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26–46.
   PubMed Web of Science ®Google Scholar
• Lee JT. Epigenetic regulation by long noncoding RNAs. Science. 2012;338:1435–1439.
   PubMed Web of Science ®Google Scholar
• Huang MJ, Zhao JY, Xu JJ, et al. lncRNA ADAMTS9-AS2 Controls Human Mesenchymal Stem Cell Chondrogenic Differentiation and Functions as a ceRNA. Mol Ther Nucleic Acids. 2019;18:533–545.
   PubMedGoogle Scholar
• Dong XZ, Zhao ZR, Hu Y, et al. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Gastric Cancer. 2020 Mar;23(2):260–272. doi:10.1002/cbin.11272. Epub 2019 Oct 24.
   Web of Science ®Google Scholar
• Le K, Guo H, Zhang Q, et al. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer. Sci Rep. 2019;9:15122.
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441–450.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
   PubMed Web of Science ®Google Scholar
• Zang H, Wang W, Fan S. The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer. Cancer Chemother Pharmacol. 2017 Feb;79(2):227–231. doi:10.1007/s00280-016-3130-7. Epub  2016 Aug 11.
   Web of Science ®Google Scholar
• Sharma N, Baruah MM. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer. Clin Transl Oncol. 2018;21:126–144.
   PubMed Web of Science ®Google Scholar
• Mandujano-Tinoco EA, Garcia-Venzor A, Melendez-Zajgla J, et al. New emerging roles of microRNAs in breast cancer. Breast Cancer Res Treat. 2018 Sep;171(2):247–259. doi:10.1007/s10549-018-4850-7. Epub  2018 Jun 9.
   Web of Science ®Google Scholar
• Srivastava SK, Ahmad A, Zubair H, et al. MicroRNAs in gynecological cancers: small molecules with big implications. Cancer Lett. 2017;407:123–138.
   PubMed Web of Science ®Google Scholar
• Xia H, Li Y, Lv X. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Int J Oncol. 2016 Oct;49(4):1325–1333. doi:10.3892/ijo.2016.3628. Epub 2016 Jul 25.
   Web of Science ®Google Scholar
• Hu CC, Liang YW, Hu JL, et al. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A. Eur Rev Med Pharmacol Sci. 2019;23:6602–6611.
   PubMed Web of Science ®Google Scholar
• Hui L, Wang J, Zhang J, et al. lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis. PeerJ. 2019;7:e7456.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Chen XF, Liu Y. MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2. Biomed Pharmacothe. 2016;81:379–387.
   PubMed Web of Science ®Google Scholar
• Hsu W, Liu L, Chen X, et al. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway. Biol Res. 2019;52:33.
   PubMed Web of Science ®Google Scholar
• Song H, Liu Y, Jin X, et al. Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop. J Cell Mol Med. 2019;23:6098–6111.
   PubMed Web of Science ®Google Scholar
• Naghashi N, Ghorbian S. Clinical important dysregulation of long non-coding RNA CCHE1 and HULC in carcinogenesis of cervical cancer. Mol Biol Rep. 2019;46:5419–5424.
   PubMed Web of Science ®Google Scholar
• Li YJ, Yang Z, Wang YY, et al. Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation. Mol Oncol. 2019;13:2375–2392.
   PubMed Web of Science ®Google Scholar
• Yu CL, Xu XL, Yuan F. LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer. Biosci Rep. 2019 Sep 13;39(9). pii: BSR20190903. doi:10.1042/BSR20190903. Print 2019 Sep 30.
   Web of Science ®Google Scholar
• Wang X, Zhang J, Wang Y. Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability. Am J Transl Res. 2019;11:4909–4921.
   PubMed Web of Science ®Google Scholar
• Chan JJ, Tay Y. Noncoding RNA:RNA Regulatory Networks in Cancer. Int J Mol Sci. 2018 Apr 27;19(5). pii: E1310. doi: 10.3390/ijms19051310.
   Web of Science ®Google Scholar
• Wang X, Xie Y, Wang J. Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2. Oncol Res. 2018;26:977–985.
   PubMed Web of Science ®Google Scholar
• Liu S, Wang H, Mu J, et al. MiRNA-211 triggers an autophagy-dependent apoptosis in cervical cancer cells: regulation of Bcl-2. Naunyn-Schmiedeberg’s Arch Pharmacol. 2020 Mar;393(3):359–370. doi:10.1007/s00210-019-01720-4. Epub  2019 Oct 21.
   Google Scholar
• Wang X, Yi Y, Lv Q, et al. Novel 1,3,5-triazine derivatives exert potent anti-cervical cancer effects by modulating Bax, Bcl2 and Caspases expression. Chem Biol Drug Des. 2018;91:728–734.
   PubMed Web of Science ®Google Scholar
• Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47:19–28.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1097–1099.
   PubMed Web of Science ®Google Scholar